IGC - IGC Pharma, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.44 -0.03 (-6.18%)	---	0.0 (0.0%)	0.0 (0.02%)	-0.02 (-5.45%)	-0.01 (-1.71%)	0.0 (0.02%)	0.0 (0.02%)

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.02
Diluted EPS:: -0.02
Basic P/E:: -20.64
Diluted P/E:: -20.64
RSI(14) 1m:: 50.38
VWAP:: 0.41
RVol:: 1.0861

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	0.41 -0.0 (-1.21%)	Oct 15 14:42
1m	Price increase 1m	0.41 +0.0 (+1.0%)	Oct 15 10:48
1m	Price decrease 1m	0.41 -0.01 (-1.52%)	Oct 15 10:42
1m	Price decrease 1m	0.42 -0.01 (-1.21%)	Oct 15 10:37
1m	Price increase 1m	0.42 +0.0 (+1.17%)	Oct 15 09:41